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Macroautophagy in lymphatic endothelial cells
inhibits T cell–mediated autoimmunity
Guillaume Harlé1, Camille Kowalski1, Juan Dubrot1, Dale Brighouse1, Gaëlle Clavel2, Robert Pick1, Natacha Bessis3, Jennifer Niven1,
Christoph Scheiermann1, Monique Gannagé3*, and Stéphanie Hugues1*
Lymphatic endothelial cells (LECs) present peripheral tissue antigens to induce T cell tolerance. In addition, LECs are the main
source of sphingosine-1-phosphate (S1P), promoting naive T cell survival and effector T cell exit from lymph nodes (LNs).
Autophagy is a physiological process essential for cellular homeostasis. We investigated whether autophagy in LECs
modulates T cell activation in experimental arthritis. Whereas genetic abrogation of autophagy in LECs does not alter immune
homeostasis, it induces alterations of the regulatory T cell (T reg cell) population in LNs from arthritic mice, which might be
linked toMHCII-mediated antigen presentation by LECs. Furthermore, inflammation-induced autophagy in LECs promotes the
degradation of Sphingosine kinase 1 (SphK1), resulting in decreased S1P production. Consequently, in arthritic mice lacking
autophagy in LECs, pathogenic Th17 cell migration toward LEC-derived S1P gradients and egress from LNs are enhanced, as well
as infiltration of inflamed joints, resulting in exacerbated arthritis. Our results highlight the autophagy pathway as an
important regulator of LEC immunomodulatory functions in inflammatory conditions.
Introduction
LN stromal cells (LNSCs) are CD45neg nonhematopoietic cells
that play an important role in LN, blood, and lymphatic vessel
architecture. They include three main subsets, the blood endo-
thelial cells (BECs; gp38−CD31+), the fibroblastic reticular cells
(FRCs; gp38+CD31−), and the lymphatic endothelial cells (LECs;
gp38+CD31+; Rodda et al., 2018). However, LNSC functions are
not restricted to their architectural role. In particular, they
regulate T cell immunity, notably by altering dendritic cell
(DC) maturation and migration (Buettner and Bode, 2011;
Podgrabinska et al., 2009). Under inflammatory conditions,
DC–LEC interactions lead to a down-regulation of costimulatory
molecules by DCs, resulting in their decreased abilities to acti-
vate naive T cells (Podgrabinska et al., 2009; Rouhani et al.,
2015). In addition, LNSCs ectopically express self-antigens
(Ags) restricted to peripheral tissues (also known as peripheral
tissue Ags [PTAs]). The direct presentation of PTAs by LNSCs via
MHC class I (MHCI) to autoreactive CD8+ T cells induces their
abortive proliferation and deletion, indicating an important
contribution of LNSCs to the maintenance of peripheral CD8+
T cell tolerance (Cohen et al., 2010; Fletcher et al., 2010; Gardner
et al., 2008; Lee et al., 2007; Magnusson et al., 2008; Nichols
et al., 2007; Yip et al., 2009). In addition, the cross-presentation
of exogenous Ags by LECs primes a small fraction of naive CD8+
T cells into long-lived memory cells capable of quickly acquiring
effector functions upon Ag rechallenge (Vokali et al., 2020). At
steady state, LNSCs express low basal levels of MHC class II
(MHCII) molecules, which are up-regulated upon inflammatory
conditions in the presence of IFN-γ (Dubrot et al., 2014). We
have shown that LNSCs contribute to CD4+ T cell tolerance by
presenting peptide–MHCII complexes acquired from DCs to in-
duce CD4+ T cell dysfunction (Dubrot et al., 2014). Other studies
have described thatMHCII expression by LNSCs, especially LECs
and FRCs, plays important roles in the homeostasis of regulatory
T cells (T reg cells; Nadafi et al., 2020; Baptista et al., 2014),
which are crucial for the regulation of (auto)immune cell acti-
vation. We recently demonstrated that the abolition of endoge-
nous MHCII expression in LNSCs induces an alteration of T reg
cells, leading to the development of spontaneous signs of auto-
immunity in elderly mice (Dubrot et al., 2018).
Additional ways for LNSCs to regulate the immune system
include the release of soluble factors such as indoleamine 2,3-
dioxygenase, nitrite oxide, or CCL21 (Lukacs-Kornek et al., 2011;
Malhotra et al., 2012; Nörder et al., 2012; Podgrabinska et al.,
2002). Furthermore, LECs are the main source of the messenger
sphingolipid sphingosine-1-phosphate (S1P; Pham et al., 2010).
S1P is produced after phosphorylation of sphingosine by two
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isoforms of Sphingosine kinase (SphK), SphK1 and SphK2, lo-
calized in the cytosol and in organelles such as the mitochondria
and nucleus, respectively (Wattenberg, 2010; Siow et al., 2010).
S1P acts through five G protein–coupled receptors (S1P1–5; Pham
et al., 2008) and plays an important role in naive T cell survival
(Mendoza et al., 2017) and effector T cell trafficking via S1P1
(Garris et al., 2014). Blockade of the S1P signaling pathway using
FTY-720 (fingolimod), an S1P receptor antagonist, inhibits T cell
egress from LNs, resulting in decreased development of auto-
immune diseases such as multiple sclerosis (Seki et al., 2010;
Kappos et al., 2006) and rheumatoid arthritis (Tsunemi et al.,
2010; Yoshida et al., 2013).
Autophagy is a physiological cellular process playing a major
role in the maintenance of cell homeostasis through the degra-
dation of protein aggregates and damaged organelles (Feng et al.,
2014). Three main pathways were described, macroautophagy,
microautophagy, and chaperone-mediated autophagy, among
which macroautophagy (herein referred as “autophagy”) has
been the most widely studied. Autophagy is highly regulated by
several genes called autophagy-related genes (Atgs) encoding
proteins implicated in the formation of autophagosomes. Among
these proteins, the complex composed by the proteins Atg5,
Atg12, and Atg16L is crucial for the initiation of autophagosome
membrane elongation (Feng et al., 2014). The protein light chain 3
(LC3) is a mammalian homologue of Atg8, which is essential for
the pathway. Throughout autophagosome generation, the cyto-
solic microtubule-associated LC3-I is conjugated to phosphatidyl-
ethanolamine (PE) to form the LC3-PE (or LC3-II) group, which is
recruited to the autophagosome membrane. LC3-interacting re-
gions (LIRs) further facilitate proteins targeting to autophago-
somes. Afterward, autophagosomes merge with lysosomes to
deliver components for enzymatic degradation (Feng et al., 2014).
Autophagy is implicated in multiple cellular functions, such
as cell cycle, lipid metabolism, and Ag presentation (Gannagé
and Münz, 2009; Mathiassen et al., 2017; Singh et al., 2009).
Several studies revealed an implication of autophagy in the
cross-presentation of exogenous Ag through MHCI by DCs in
inflammatory contexts such as tumors or viral infection (Li
et al., 2009; Loi et al., 2016; Uhl et al., 2009). Moreover, au-
tophagy is implicated in MHCII-restricted Ag presentation. In
medullary thymic epithelial cells (mTECs), autophagy contrib-
utes to self-Ag loading onto MHCII, therefore participating in
the negative selection of auto-reactive CD4+ T cells (Aichinger
et al., 2013). In DCs, autophagy allows the loading of intracellular
viral Ags ontoMHCII, thus enhancing viral CD4+ T cell responses
(Münz, 2009). In experimental autoimmune encephalomyelitis,
autophagy deletion in DCs inhibits encephalitogenic CD4+ T cell
priming and therefore disease development (Bhattacharya et al.,
2014; Alissafi et al., 2017). In contrast, autophagy deletion in DCs
in arthritic mice impairs their ability to maintain T reg cell
functions and stability, leading to their conversion toward T
helper 17 (Th17) cells (Niven et al., 2019). Thus, autophagy plays
crucial immunomodulatory roles in mTECs and DCs. However,
the role of autophagy in LNSCs, which are important actors of
peripheral T cell responses, has not been investigated yet.
Here, we investigated whether autophagy in LNSCs affects
the development of T cell–mediated autoimmune disease. We
demonstrated that in collagen-induced arthritis (CIA), a Th1/
Th17-mediated experimental arthritis mouse model, autophagy
abrogation in LECs results in decreased T reg cell proliferation
and expression of CD103 in inflamed LNs. Together with other
studies showing a role for MHCII expression by LECs in pro-
moting T reg cell functions, our data suggest a crosstalk between
the autophagy pathway andMHCII-restricted Ag presentation in
LECs impacting T reg cells. In addition, our results revealed a
novel role of autophagy in LECs in regulating the degradation of
kinases implicated in the production of S1P, therefore inhibiting
pathogenic effector Th17 cell egress from LNs and dampening
T cell–mediated autoimmunity. Altogether, our study brings
new insight into the implication of autophagy in the immuno-
modulatory functions of LECs under inflammatory settings.
Results
LC3+ autophagosomes are induced in LECs during CIA
To determine whether autophagy in LNSCs regulates autoim-
munity, we first assessed intracellular LC3-II levels in LECs,
BECs, and FRCs under autoimmune settings in vivo. We used the
mouse model of rheumatoid arthritis, CIA. C57BL/6 mice were
immunized at day 0 and day 21 (boost) with chicken type II
collagen (col2a1; Inglis et al., 2008). Autophagosome formation
was evaluated in LNSCs at different time points (Fig. 1 A). We
used a fluorescently labeled antibody against LC3 combinedwith
a permeabilization buffer, allowing the release of the LC3 cy-
toplasmic form (LC3-I) while the membrane form (LC3-II), as-
sociated with autophagosome membranes, is retained inside the
cells. Steady-state LN LECs, BECs, and FRCs (day 0) exhibited
detectable basal levels of intracellular LC3-II (Fig. 1 A), with BECs
exhibiting lower levels compared with the other two pop-
ulations. In addition, whereas BECs maintained negligible levels
of intracellular LC3-II upon CIA development in LNs draining
the site of immunization, both LECs and FRCs demonstrated a
significant increase in intracellular LC3-II levels at different
time points during CIA (Fig. 1 A). Interestingly, the kinetics of
up-regulation appeared different in LECs and FRCs, with earlier
induction of the pathway in LECs (from day 21, significant fold
change of 1.4 related to day 0) compared with FRCs (from day 31,
significant fold change of 1.7 related to day 0). These results
were confirmed in LECs and FRCs sorted by flow cytometry
from LNs draining the site of CIA induction in LC3-GFP mice
(Mizushima et al., 2004). Both populations demonstrated low
basal levels of intracellular LC3-GFP+ autophagosomes at steady
state and a significant induction of LC3-GFP+ autophagosome
formation at day 21 after CIA induction (Fig. 1 B). Again, the fold
increase of LC3-GFP+ organelles upon CIA was higher in LECs
compared with FRCs at day 21 (five vs. two, respectively), sug-
gesting that LECs activate the autophagy pathway earlier com-
pared with FRCs during CIA development.
Autophagy in LECs regulates the development of CIA
To address whether the early and significant induction of
autophagy in LECs during CIA has an impact on disease de-
velopment, we generated genetically modified mice in which
autophagy is deleted in LECs. Prox1creERT2 mice, which express
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the tamoxifen (Tx)-inducible cre recombinase under the pro-
moter of the transcription factor Prox1 (Bazigou et al., 2011),
essential for LEC differentiation and maintenance, were crossed
with Atg5flox mice. Atg5 is one of the autophagy-related proteins
indispensable for the early steps of autophagosome formation
(Ye et al., 2018; Hara et al., 2006). To verify the specific deletion
of autophagosome formation in LECs in Prox1creERT2 × Atg5flox
(Atg5ΔProx1) mice upon Tx treatment, LECs and FRCs were
Figure 1. CIA-mediated inflammation induces autophagy in LECs. (A and B) CIA was induced in WT (A) and LC3-GFP (B) mice by injecting an emulsion of
CFA with chicken type II collagen (col-II). (A) Intracellular LC3-II levels (LC3 median–FMO) were assessed by flow cytometry in LECs, BECs, and FRCs at
indicated time points. Data are representative of two independent experiments with four or five mice for each time point. Error bars correspond to lower and
higher values for each group. Two-way ANOVA. (B) LECs and FRCs were sorted from dLNs at day 0 and day 21, and autophagosomes (intracellular LC3-GFP+
organelles) were assessed by microscopy. Representative images are provided. Histograms represent the number of GFP+ organelles/cell. Data are pooled from
five individual mice. Unpaired t test; * P < 0.05, ** P < 0.01, and *** P < 0.001.
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generated from LN cultures of Atg5ΔProx1 and Atg5flox (Atg5WT)
mice as controls. Cells were cultured either in complete medium
or in starvation condition (in HBSS devoid of FBS) and treated
with chloroquine (CQ) to induce and stabilize autophagosomes.
After starvation, a significant increase of LC3-II levels was ob-
served in both LECs and FRCs from Atg5WTmice, confirming the
ability of LECs and FRCs to induce autophagy in vitro. In con-
trast, whereas FRCs from Atg5ΔProx1 mice retained this ability,
the increase of LC3-II levels in LECs from Atg5ΔProx1 mice was
fully abrogated, validating in vitro the abrogation of autopha-
gosome formation in LECs in these mice (Fig. 2 A). To further
validate the conditional deletion of autophagy in LECs in vivo,
Atg5ΔProx1 and Atg5WT mice were treated with IFN-γ to induce
inflammation and CQ to accumulate the autophagosomes. LC3
staining demonstrated that LC3-II+ autophagosomes accumu-
lated in LN LECs and FRCs from Atg5WT mice, whereas BECs
maintained very low levels of LC3, themedian being comparable
to the FMO (full minus one; Fig. 2 B). In contrast, whereas FRCs
and BECs from Atg5ΔProx1 mice behaved as their control litter-
mates, LN LECs from Atg5ΔProx1 mice exhibited a significant LC3
median reduction compared with Atg5WT LECs (Fig. 2 B).
Moreover, to determine whether autophagy was also deleted in
skin LECs during inflammation, we measured the accumulation
of the protein p62, which interacts with ubiquitinylated pro-
teins to target them toward autophagosomes and is therefore
itself degraded when the pathway is active (Lippai and Lőw,
2014). P62 was stained on back skin sections from Atg5ΔProx1
and Atg5WT mice immunized with OVA + complete Freund’s
adjuvant (CFA). We did not observe any p62 staining in skin
LECs from immunized Atg5WT mice, indicating that under in-
flammation, the protein is degraded by the autophagy pathway.
In contrast, p62 accumulated in skin LECs from immunized
Atg5ΔProx1 mice, confirming the abrogation of autophagy in
these cells (Fig. 2 C). Therefore, autophagy is efficiently abro-
gated in LN and skin LECs from Atg5ΔProx1 mice. 2 wk and 2 mo
after Tx treatment, naive Atg5ΔProx1 and Atg5WT mice did not
reveal any alteration in LNSC repartition in LNs (Fig. 2, D and
E). Lyve-1 staining on Atg5ΔProx1 and Atg5WT steady-state LN
sections did not indicate any alterations of lymphatic vessel
structure (Fig. 2 F). In addition, frequencies of B cells, macro-
phages, and LN resident and migratory DCs, as well as their
expression of costimulatory molecules (CD80, CD86), were not
altered in LNs from naive Atg5ΔProx1 and Atg5WT mice 2 mo after
Tx injection (Fig. S1 A). Similarly, we did not observe any effect
on natural killer cell and neutrophil frequencies (Fig. S1 A). LN
structure did not seem to be affected by the Tx treatment at
steady state, exhibiting normal T and B cell zones (Fig. S1 B), and
peripheral LN weights were found to be similar as well (Fig. S1
B). Accordingly, 2 wk and 2 mo after Tx treatment, naive
Atg5ΔProx1 and Atg5WT mice did not reveal any alteration in the
T cell compartment, neither in lymphoid organs (such as skin
LNs and spleen; Fig. S2, A and B) nor in peripheral tissues (such
as in salivary glands and lungs; Fig. S2, C and D). Finally, the
frequencies of Th1 and Th17 cells in LNs are also similar at
steady state in Atg5ΔProx1 and Atg5WT LNs (Fig. S2 E). Altogether,
our results indicate that the immune system in Atg5ΔProx1 mice
is similar to that of Atg5WT mice at the baseline before CIA
induction, indicating that autophagy in LECs does not impact
naive T cell homeostasis at steady state.
We next assessed the impact of autophagy deletion in LECs
during CIA by evaluating clinical scores (paw thickness) in
Atg5ΔProx1 and Atg5WT mice. Both groups exhibited similar dis-
ease onset (at day 31; Fig. 3 A). However, Atg5ΔProx1 mice de-
veloped more severe clinical scores compared with Atg5WT mice
(mean score of 4 at peak disease in Atg5ΔProx1 compared with 1.5
in Atg5WT mice; Fig. 3 A) associated with an increased incidence
(100% in Atg5ΔProx1 compared with 75% in Atg5WT mice at day
48). Disease exacerbation was confirmed by histological analy-
sis, which revealed increased inflammatory scores in knees from
Atg5ΔProx1 compared with Atg5WT mice (Fig. 3 B). Furthermore,
mRNA levels of inflammatory markers described as playing key
roles during the acute phase of CIA, such as IL-6 and serum
amyloid A (SAA; Yoshida and Tanaka, 2014; Cunnane et al.,
2000), were increased in paws from Atg5ΔProx1 mice at day 31
of CIA compared with Atg5WT mice (Fig. 3 C). To confirm the
role of autophagy in LECs on disease severity, CIA was induced
in a second conditional LEC knockout expressing Tx-inducible
cre recombinase under the promoter Flt4 (VEGF-C receptor,
expressed by LECs) crossed with Atg5flox mice (Atg5ΔFlt4). Sim-
ilar to Atg5ΔProx1 mice, clinical scores were exacerbated and CIA
incidence increased in Atg5ΔFlt4 compared with Atg5WT mice
(Fig. 3 D; and incidence of 100% in Atg5ΔProx1 compared with
60% in Atg5WT mice at day 48).
We next analyzed T cells infiltrating the hind leg joints from
Atg5ΔProx1 and Atg5WT mice at day 31 after CIA. Infiltrating T cell
frequencies and numbers, and mostly CD4+ T cells, were sig-
nificantly increased in joints from Atg5ΔProx1 mice compared
with Atg5WT mice (Fig. 3 E). No variation was observed for Th1
cell populations. In contrast, effector Th17 cell frequencies and
numbers were significantly augmented in joints from Atg5ΔProx1
mice (Fig. 3 E), which is consistent with the increased CIA se-
verity observed in these mice (Fig. 3 A). Altogether, our data
demonstrate that the abrogation of autophagy in LECs results in
CIA exacerbation and enhanced Th17 cells in joints.
Does autophagy contribute to MHCII-restricted Ag
presentation in LECs?
It was previously demonstrated that autophagosomes can
target some Ags to MHCII+ compartments in mTECs and DCs
(Aichinger et al., 2013; Münz, 2009). Therefore, we wondered
whether autophagy abolition in LECs could impact their MHCII-
restricted Ag-presenting functions and affect CD4+ T cell re-
sponses. We first assessed MHCII levels in LECs during CIA.
LECs significantly up-regulated MHCII molecules as early as
26 d after CIA induction (4.3-fold change compared with day
0; Fig. 4 A). Interestingly, MHCII up-regulation and intracel-
lular LC3-II accumulation in LECs during CIA (Fig. 1) followed
similar kinetics. To determine whether a crosstalk exists be-
tween autophagy and MHCII-restricted Ag presentation
pathways in LECs, LC3-GFP mice were treated with IFN-γ to
induce MHCII up-regulation in LECs and further treated with
CQ to stabilize autophagosomes. LECs sorted from LNs draining
the immunization site by flow cytometry 24 h later demon-
strated an intracellular colocalization of MHCII+ organelles with
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Figure 2. Autophagy is abolished in LNs and skin LECs from Atg5ΔProx1 mice but does not impair stromal frequencies and lymphatic vessel orga-
nization in steady-state LNs. (A–F) Atg5WT and Atg5ΔProx1 mice were treated with Tx. (A) LEC/FRC cultures from LNs of Atg5WT and Atg5ΔProx1 mice were
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LC3-GFP+ autophagosomes, suggesting an efficient targeting of
autophagosomes to MHCII loading compartments (Fig. 4 B).
LNSCs express a broad range of PTAs (Cohen et al., 2010;
Fletcher et al., 2010; Gardner et al., 2008; Lee et al., 2007; Nichols
et al., 2007; Yip et al., 2009). Interestingly, the type II collagen
(col2a1), the endogenous protein used to induce CIA in mice, was
described as being expressed by LECs, BECs, and FRCs (Malhotra
et al., 2012). We confirmed the expression of some PTA mRNAs
in LNSCs, including the col2a1 (Fig. 4 C), and determined
whether some amino acid sequences in LNSC-expressed PTAs
would predict their targeting to autophagosomes. Most of the
PTAs tested contained amino acid sequences matching with LC3-
interacting (LIR) motifs in the iLIR server (Kalvari et al., 2014)
and predicting an efficient targeting to the autophagy pathway
(Fig. 4 C). Position-specific scoring matrix (PSSM) scores of >12
were shown to give reliable predictions for an attachment to LC3
(Klionsky et al., 2016). Therefore, PTAs expressed by LNSCs
exhibit the potential to be targeted toward autophagosomes.
Together with a substantial colocalization between MHCII+ or-
ganelles and LC3+ compartments in LECs, our results indicate a
possible crosstalk between autophagy and MHCII-restricted Ag
presentation pathway in these cells.
MHCII abrogation in LECs exacerbates CIA
We next induced CIA in mice lacking MHCII expression by
LECs generated through the crossing of Prox1creERT2 mice with
MHCIIflox (MHCIIΔProx1) mice. Similar to Atg5ΔProx1 mice,
MHCIIΔProx1 mice exhibited an increased disease severity com-
pared with MHCIIflox (MHCIIWT) control mice, as demonstrated
by enhanced clinical scores (Fig. 5 A). Moreover, histological
analysis of MHCIIΔProx1 knees revealed a tendency of enhanced
inflammation compared with MHCIIWT control knees (Fig. 5 B).
Although T cell frequencies were unaffected, numbers of T cells,
mainly CD4+ T cells, infiltrating the hind leg joints were in-
creased in MHCIIΔProx1 mice 31 d after CIA immunization (Fig. 5
C). In contrast to Atg5ΔProx1 mice, Th17 remained unchanged in
joints from CIA MHCIIΔProx1 mice compared with controls.
However, infiltrated Th1 cell numbers were significantly in-
creased in joints from MHCIIΔProx1 mice (Fig. 5 C), supporting
CIA exacerbation in these animals.
Abolition of autophagy or MHCII in LECs results in T reg
alterations in draining LNs (dLNs) during CIA
We and others have previously shown that MHCII expression in
LECs is important for T reg cell programming (Dubrot et al.,
2018; Nadafi et al., 2020). At earlier time points (days 26
and 31 after CIA induction), although no variation in T reg
cell (CD4+FoxP3+) frequency was observed in Atg5ΔProx1 and
MHCIIΔProx1 dLNs (Fig. 6 A and Fig. S3 A), T reg cells were found
to be less proliferative (Ki67+) than their respective control mice,
while the proliferation of conventional T cell (T conv cell;
CD4+FoxP3−) was not affected (Fig. 6 B and Fig. S3 B). T reg cells
can be further separated based on their expression levels of
CD25 (neg, low, and high; Fig. 6, C and D; and Fig. S3, C and D),
the highest expression having been correlated with enhanced T
reg cell suppressive functions (Miyao et al., 2012; Komatsu et al.,
2009).
CD103 is an α-E integrin described as playing an important
role in T reg cell retention at inflamed sites (Suffia et al., 2005).
We observed that CD103 expression levels by T reg cells posi-
tively correlated to their expression levels of CD25 (Fig. 6, C and
D; and Fig. S3, C and D). However, the frequency of T reg cells
expressing CD103, as well as CD103 levels of expression by LN T
reg cells from Atg5ΔProx1 and MHCIIΔProx1 mice, was reduced
compared with control mice (Fig. 6, C and D; and Fig. S3, C and
D). Elevated CD103 expression was particularly impaired in the
CD25high T reg cell population in LNs from Atg5ΔProx1 and
MHCIIΔProx1 mice (Fig. 6, C and D; and Fig. S3, C and D). In
contrast, neither MHCII abrogation nor autophagy deletion in
LECs alters the expression of PD1 and ICOS by T reg cells (not
shown). Therefore, autophagy or MHCII abolition in LECs re-
sults in alteration in T reg cell proliferation and CD103 expres-
sion in dLNs. Both autophagy and MHCII deletion in LECs
induced an increase in CIA severity, associated with decreased T
reg cell frequencies and an altered T reg phenotype in dLNs.
Interestingly, decreased expression of CD103 by LN T reg cells
correlated with diminished levels of CD103 expression by T reg
cells present in arthritic joints of Atg5ΔProx1 mice compared with
control mice (Fig. 6 E).
MHCII deletion, but not autophagy, in LECs impaired T reg cell
suppressive functions under inflammatory conditions
FoxP3 expression levels were positively correlated with T reg
cell suppressive functions (Fontenot et al., 2003). Therefore, we
characterized T reg cell frequencies and Foxp3 expression 20 d
after CIA onset in LNs draining the immunization site of
Atg5ΔProx1, MHCIIΔProx1, and their respective control mice.
FoxP3+ T reg cell frequencies were decreased during the CIA
chronical phase in both Atg5ΔProx1 and MHCIIΔProx1 mice com-
pared with control animals (day 50 and day 41, respectively),
associated with increased in T conv frequencies (Fig. 7 A). A
positive correlation has been established between CD25 ex-
pression levels and an increased stability of the transcription
factor FoxP3, together with enhanced suppressive functions
(Komatsu et al., 2009; Miyao et al., 2012). FoxP3 expression was
down-regulated in T reg cells fromMHCIIΔProx1 dLNs, regardless
of their expression levels of CD25 (Fig. 7 A), whereas FoxP3
expression levels remained unchanged in dLNs of Atg5ΔProx1
treated or not treated with CQ for 4 h, and intracellular LC3 levels (LC3-II) were assessed by flow cytometry (two independent experiments with two or three
mice/group). (B) Atg5WT and Atg5ΔProx1 mice were injected with IFN-γ and CQ. CD45neg cells were isolated from skin LNs 24 h after, and intracellular LC3 levels
(LC3-II) were assessed in LECs, BECs, and FRCs by flow cytometry. Unpaired t test; ** P < 0.01, three to five mice/group. (A and B) Error bars correspond to
SEM. (C) Sections showing intracellular p62 in LECs (Lyve1+) from back skin of Atg5WT and Atg5ΔProx1 mice 5 d after OVA + CFA immunization. Representative
images, three independent mice/group. (D and E) LEC, BEC, and FRC frequencies in skin LNs 2 wk (2wk, gated on CD45negTer119neg; D) and 2 mo (2mo, gated
on CD45neg; E) after Tx treatment. Error bars correspond to lower and higher values for each group. (F) 2 mo later, lymphatic vessels (Lyve1+) were analyzed on
sections of skin LNs from Atg5WT and Atg5ΔProx1 mice 2 mo after Tx treatment. Images show LNs from individual mice.
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Figure 3. Autophagy in LECs dampens CIA severity. (A–C) CIA was induced in Tx-treated Atg5WT and Atg5ΔProx1 mice. (A) Clinical scores (paw thickness)
were assessed at indicated time points. Data are representative of two independent experiments with six to eight mice/group. (B) Inflammatory scores were
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mice (Fig. 7 A). These results indicate that LN T reg cells might
exhibit an altered ability to inhibit T cell activation in the ab-
sence of MHCII expression by LECs.
To further characterize whether MHCII expression and/or
autophagy in LECs might regulate T reg cell suppressive func-
tions during CIA, we performed ex vivo suppressive assays to
assess the ability of T reg cells isolated from LNs of Atg5ΔProx1
and MHCIIΔProx1 CIA mice to inhibit T cell proliferation. To sort
T reg cells based on a specific FoxP3 fluorescent reporter, we
generated bone marrow (BM) chimeric mice. Lethally irradiated
Atg5ΔProx1 and MHCIIΔProx1 mice and their respective controls
were injected with BM cells from FoxP3-RFP mice. T reg cells
(RFP+ cells) were sorted from dLNs of BM chimeras 26 d after
CIA induction and cultured at different ratios with naive cell
trace violet (CTV)–labeled CD25−CD4+ T cells stimulated with
anti-CD3 antibodies and BM-derived DCs (Fig. 7 B). T reg cells
fromMHCIIΔProx1 mice exhibited an impaired ability to suppress
the proliferation of naive T cells, as revealed by a higher division
index (ratio 1:5) compared with naive T cells incubated with
MHCIIWT T reg cells (Fig. 7 B). In contrast, T reg cells from
Atg5ΔProx1 mice displayed suppressive functions comparable to T
reg cells from control mice (Fig. 7 B). Therefore, although au-
tophagy might contribute to MHCII-restricted Ag presentation
by LECs, other unrelated pathways confer the ability of LECs to
present Ags through MHCII molecules to promote T reg cell
suppression.
To further decipher the contribution of T reg cells to CIA
exacerbation in the absence of autophagy in LECs, Atg5ΔProx1 and
Atg5WT CIA mice were treated with an anti-CD25–depleting
antibody. T reg cells were efficiently depleted in the blood of
treated mice compared with untreated controls (Fig. 7 C). As
expected, untreated Atg5ΔProx1 mice exhibited higher clini-
cal scores compared with Atg5WT mice (Fig. 7 D). Moreover,
T reg cell depletion resulted in CIA exacerbation in Atg5WT
mice, confirming an implication of T reg cells in regulating
disease development (Sun et al., 2018). Interestingly, T
reg–depleted Atg5WT mice still exhibited significantly lower
clinical scores compared with T reg–depleted Atg5ΔProx1
mice (Fig. 7 D). Disease exacerbation between T reg–deleted
Atg5ΔProx1 and Atg5WT mice was less pronounced compared
with the exacerbation observed in untreated mice, which
can be explained by T reg cell alterations existing in the
absence of autophagy LECs. However, under these settings
of a slowly evolving inflammatory reaction, it is difficult to
determine whether T reg cell alterations in Atg5ΔProx1 mice
are a cause or a consequence of disease exacerbation. Alto-
gether, our results reveal that alterations of the T reg cell
compartment in the absence of autophagy in LECs do not
entirely explain CIA exacerbation and that autophagy in
LECs regulates other pathways implicated in the modulation
of disease severity.
Abolition of autophagy in LECs affects Th17 egress from LNs in
an S1P-dependent manner
To decipher the additional mechanisms accounting for CIA ex-
acerbation in Atg5ΔProx1 mice, we next characterized pathogenic
Th1 and Th17 cells in LNs draining the site of disease induction at
days 26 and 31. Whereas IFN-γ–producing Th1 CD4+ cell fre-
quencies were not affected by the loss of autophagy in LECs, LNs
from Atg5Prox1 mice surprisingly exhibited a significant decrease
in the frequency of IL-17–producing Th17 CD4+ T cells compared
with Atg5WT mice (Fig. 8 A). This result was not observed in
MHCIIΔProx1 mice (Fig. 8 B), supporting an MHCII-independent
regulation of Th17 cell responses in mice lacking autophagy in
LECs. The decrease of Th17 cells observed in LNs, together with
the increase of joint-infiltrating Th17 cells (Fig. 3 E), might in-
dicate a modulation of the Th17 organ migration pattern in
Atg5Prox1 mice.
We hypothesized that autophagy in LECs regulates the
homing of Th17 cells from LNs to inflamed joints during CIA. An
important pathway by which LECs influence T cell responses is
by regulating effector T cell egress from the LNs through the
production of S1P. To determine whether the decrease of Th17 in
dLNs of Atg5ΔProx1 is indeed a consequence of enhanced egress,
CIA-induced Atg5ΔProx1 and Atg5WT mice were treated or not
with the S1P receptor antagonist FTY-720, which blocks lym-
phocyte egress from LNs (Fig. 8 C). In untreated animals, we
recapitulated a significant decrease in Th17 frequencies at day 31
in dLNs from Atg5ΔProx1 compared with Atg5WT mice, with again
no variation in Th1 cells (Fig. 8 D). However, FTY-720–treated
Atg5ΔProx1 and Atg5WT mice exhibited similar frequencies com-
pared with untreated mice for both Th1 and Th17 cells in dLNs
(Fig. 8 D). These results demonstrate that autophagy in LECs
does not impact the priming of pathogenic Th1 and Th17 cells
during CIA, but rather, as also supported by the increase in Th17
cells in joints of arthritic Atg5ΔProx1 mice (Fig. 3 E), regulates the
egress of Th17 cells from LNs. In striking contrast, decreased
frequencies of both FoxP3+ T reg and of CD103+FoxP3+ T reg cells
were maintained in LNs of Atg5ΔProx1 mice upon FTY-720
blockade, showing that the lack of autophagy in LECs alters the
priming of CD103+ T reg cells in LNs upon CIA induction (Fig. 8
E). Therefore, although the pathway has no effect on the priming
of pathogenic Th1 and Th17 cells, autophagy in LECs promotes
the differentiation/expansion of CD103+ T reg cells in LNs, re-
sulting in higher expression of CD103 by T reg cells localized in
arthritic joints (Fig. 6 E).
Interestingly, LN exit of Th17 cells but not Th1 cells was
impacted by the abrogation of autophagy in LECs, suggesting
assessed by histology analysis of knee sections at day 50 (six or sevenmice/group). Representative images are provided, and arrowheads indicate inflammatory
areas. Histograms represent global inflammation scores (sum of two knees per mouse). (C)mSAA and IL-6 mRNA levels in dLNs and paws at day 31 of CIA (four
to six mice/group). (D) CIA was induced in Tx-treated Atg5WT and Atg5ΔFlt4 mice. Clinical scores (paw thickness) were assessed at indicated time points. Data
are representative of two independent experiments with six to eight mice/group. (E) CIA was induced in Tx-treated Atg5WT and Atg5ΔProx1 mice. Flow cy-
tometry analysis of indicated T cell subsets infiltrating hind-joint legs at day 31 (five or six mice/group). Representative dot plots are provided. Histograms
represent the frequencies or the numbers of indicated cells in joints. Two-way ANOVA (A and D) and unpaired t test (B, C, and E). * P < 0.05, ** P < 0.01, and
*** P < 0.001. Error bars correspond to lower and higher values for each group (B, C, and E) and to SEM (A and D).
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Figure 4. Contribution of autophagy to MHCII-restricted presentation of PTA by LECs. (A) CIA was induced in WT mice, and MHCII expression levels
were assessed by flow cytometry in dLN LECs at indicated time points. Data represent MHCII expression levels (median–FMO) and are representative of two
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that different CD4+ T cell subsets might exhibit distinct levels of
sensitivity to S1P gradients. Since the type 1 receptor for S1P,
S1P1, is the main S1P receptor implicated in T cell egress (Garris
et al., 2014), we assessed S1P1 expression levels in different CD4+
T cell subsets from LNs draining immunization sites day 31 after
CIA induction. Strikingly, Th17 cells expressed significantly
greater S1P1 levels compared with both T reg and Th1 cells
(Fig. 8 F), which is consistent with the hypothesis that this
particular effector T cell subset would be more sensitive to S1P
gradients and their modulations by the autophagy pathway
in LECs.
Inflammation-induced autophagy modulates S1P production
by regulating SphK1 levels in LECs to inhibit Th17 egress
from LNs
One possibility is that our observations are consequence rather
than the cause of more severe CIA in Atg5ΔProx1 mice. To de-
termine whether inflammation-induced autophagy in LECs in-
deed regulates their ability to (1) promote T reg cells in LNs and
(2) provide a local S1P gradient to modulate effector T cell egress
from LNs, we performed experiments using a short-term in-
duced inflammationmodel. Atg5ΔProx1 and Atg5WTmicewere s.c.
immunized with OVAII and CFA. 5 d later, recapitulating the
results obtained with CIA mice, we observed a decrease of Th17
cell and T reg cell frequencies in dLNs of Atg5ΔProx1 mice,
without any difference in Th1 cell frequency (Fig. 9, A and B). In
addition, and similar to the CIA settings, Th17 cells expressed
higher levels of S1P1 compared with both T reg and Th1 cells
(Fig. 9 C). To assess the localization of Ag-specific Th17 cells in
LNs, the same experiment was repeated by transferring OVA-
specific TCR transgenic OT-II CD4+ T cells crossed with RORγt+
GFP mice 1 d before OVAII + CFA immunization. 5 d after im-
munization, Th17 (RORγt-GFP+) OT-II cells localized signifi-
cantly closer to medullar LECs (Lyve1+) in dLNs from Atg5ΔProx1
compared with Atg5WT mice (Fig. 9 D). Altogether, these data
demonstrate that upon short-term induced inflammation, LN
LECs activate the autophagy pathway, leading to decreased T reg
and Th17 cell frequencies, the latter likely being a consequence
of impaired Th17 cell egress from inflamed LNs. We assessed
whether the structure of LN or skin LECs or lymphatic vessel
drainage functions could be altered under inflammatory settings
by the loss of autophagy in LECs and play a role in our ob-
servations. Lyve-1 staining on sections of LN and skin from
Atg5ΔProx1 and Atg5WT immunized mice did not reveal any al-
terations of lymphatic vessel structure (Fig. S4, A and B). Fur-
thermore, lymphatic drainage, measured by the flow out of
Alexa Fluor 488–dextran from skin to dLNs, appeared similar
in both Atg5ΔProx1 and Atg5WT immunized mice (Fig. S4 C).
Therefore, abrogation of autophagy in LECs does not affect their
structure and drainage functions.
As LECs represent the main source of S1P production in LNs
(Pham et al., 2010), we wondered whether autophagy in LECs
directly impacts S1P production and consequently alters lym-
phocyte egress from LN. Two different enzymes, SphK1 and
SphK2, respectively, are implicated in the generation of S1P.
Analysis of amino acid sequences of SphK1 and SphK2 using the
iLIR database software revealed that both enzymes exhibited
LC3 interacting motifs. However, only SphK1 LIR motifs dis-
played a PSSM score >12, predicting an efficient targeting for
SphK1, but not for SphK2, toward autophagosomes (Fig. S5 A). In
vitro starvation of LC3-GFP LECs further showed that autopha-
gosomes (LC3-GFP+) colocalized with SphK1 but not with SphK2
(Fig. 9 E and Fig. S5 B). Western blot analysis revealed that
following starvation, Atg5WT LECs exhibited higher levels of
LC3-II, validating the induction of autophagosome formation
(Fig. 9 F). Interestingly, this observation was associated with
decreased SphK1 protein level in Atg5WT LECs (Fig. 9 F), estab-
lishing a direct link between autophagy induction and SphK1
degradation inWT LECs, and supporting a negative regulation of
S1P production by autophagy in LECs. In striking contrast, LC3-
II induction or SphK1 reduction was absent in Atg5ΔProx1 LECs
upon starvation, indicating that autophagy in LECs regulates
SphK1 protein levels (Fig. 9 F). Transcriptional analysis of LECs
sorted from LNs of CIA mice at day 31, which display high au-
tophagy levels (Fig. 1), did not reveal any variation in the ex-
pression of genes implicated in S1P production (SphK1 and
2 kinases) or in S1P degradation (SPGL1 lyase; Fig. S5 C). Thus,
reduced levels of SphK1 observed in Atg5WT LECs upon starva-
tion (Fig. 9 E) are a consequence of protein degradation and not a
regulation of gene expression. Similar results were obtained
after starvation of human intestinal LECs (iLECs). Although LC3
signal was lower in starvation condition (possibly a consequence
of protein degradation following the activation of the autophagy
pathway in these cells), the LC3-II/LC3-I ratio was increased and
was associated with a total degradation of SphK1 (Fig. S5 D).
To determine whether this novel pathway in LECs has an
impact on T cell migration toward S1P gradients, in vitro
transmigration assays were performed using Atg5ΔProx1 or
Atg5WT LECs, starved or not, and activated CD4+ T cells, pre-
treated or not with FTY-720. Transmigration of activated CD4+
T cells was analyzed 4 h later by flow cytometry. FTY-720
treatment inhibited T cell transmigration toward Atg5WT LECs,
confirming that effector T cells are sensitive to S1P production
by LECs (Fig. 9 G). Inhibition of T cell transmigration was also
observed after starvation of Atg5WT LECs, indicating that au-
tophagy in LECs might impair their ability to induce T cell mi-
gration. Accordingly, starvation of Atg5ΔProx1 LECs did not
compromise T cell transmigration (Fig. 9 G). We further vali-
dated these results using an inflammatory stimulus instead of
starvation. LECs isolated from LC3-GFP mice treated with IFN-γ
independent experiments with four or five mice for each time point. One-way ANOVA; * P < 0.05 and *** P < 0.001. Error bars correspond to lower and higher
values for each group. (B) LC3-GFP mice were injected s.c. with IFN-γ and CQ. LECs were sorted from dLNs, and colocalization of autophagosomes (LC3-GFP+
organelles) and MHCII compartment was examined by microscopy. (C) Pattern of indicated PTA mRNA expressed by LECs, BECs, and FRCs sorted from steady-
state LNs (pool of three or four mice) and PSSM scores of their amino acid sequences determining their potential targeting toward autophagosomes (iLIR
database software).
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exhibit an activation of the autophagy pathway (Fig. S5 E).
Therefore, we performed in vitro activated T cell transmigration
assays by using IFN-γ–treated WT LECs. We confirmed that this
inflammatory stimulus impairs S1P-mediated T cell transmigration
toward LECs (Fig. S5 F). Altogether, these results show that au-
tophagy regulates the ability of LECs to induce S1P-mediated T cell
transmigration. In agreement with this hypothesis, amounts of
S1P in supernatant from Atg5ΔProx1 LEC cultures were significantly
Figure 5. Abolition of MHCII in LECs exacerbates CIA. (A–C) CIA was induced in Tx-treated MHCIIWT and MHCIIΔProx1 mice. (A) Clinical scores (paw
thickness) were assessed at indicated time points. Data are representative of two independent experiments with six to eight mice/group. (B) Inflammatory
scores were assessed by histological analysis on knee sections at day 41 (seven or eight mice/group). Representative images are provided, and arrowheads
indicate areas of inflammation. Histograms represent global inflammation scores (sum of two knees per mouse). (C) Flow cytometry analysis of indicated T cell
subsets infiltrating hind-joint legs at day 31, five or six mice/group. Representative dot plots are provided. Histograms represent the frequencies or the
numbers of indicated cells in joints. Two-way ANOVA (A) and unpaired t test (B and C); * P < 0.05 and ** P < 0.01. Error bars correspond to SEM (A) and to
lower and higher values for each group (B and C).
Harlé et al. Journal of Experimental Medicine 11 of 24
Autophagy in LECs inhibits CIA https://doi.org/10.1084/jem.20201776
Figure 6. Abolition of autophagy in LECs alters LN T reg cells during CIA. (A–E) CIA was induced in Tx-treated Atg5WT and Atg5ΔProx1 mice. (A and B) Flow
cytometry analysis of T reg cells (FoxP3+CD4+ cells) and T conv cells (FoxP3−CD4+ cells) in dLNs at days 26 and 31. Cell frequency (A) and proliferation rate
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increased compared with Atg5WT LECs (Fig. 9 H). Altogether, our
data demonstrate that autophagy alters the ability of inflamed LECs
to promote effector T cell migration, and more particularly Th17
cells, in an S1P-dependent manner by regulating SphK1 but not
SphK2 protein levels.
Discussion
LECs are important contributors to the shaping of immune re-
sponses. In particular, by presenting endogenously expressed
PTA to autoreactive T cells, they play a major role inmaintaining
peripheral T cell tolerance (Cohen et al., 2010; Lee et al., 2007;
Magnusson et al., 2008; Nichols et al., 2007; Dubrot et al., 2014).
Here, we show that LECs regulate the development of CIA in
C57BL/6 mice and that autophagy plays a crucial role in LEC
immunomodulatory functions. Disease-mediated inflammation
activates the autophagy pathway in LECs, leading on the one
hand to an adjustment of the T reg cell frequencies and CD103
expression and, on the other hand, to an inhibition of pathogenic
Th17 egress from LNs and subsequent homing to inflamed joints.
Studies have described LECs as MHCII-restricted Ag-
presenting cells impacting T reg cell proliferation and differ-
entiation (Nadafi et al., 2020; Baptista et al., 2014; Dubrot et al.,
2018). However, whether the autophagy pathway is active in
LECs and implicated in LEC Ag-presenting functions is still
unknown. Our results demonstrate that autophagy is actively
induced in LECs in LNs draining the site of CIA induction. Au-
tophagy abolition in LECs results in alterations in the T reg cell
population in dLNs, with impaired proliferation and decreased
CD103 expression. This effect was recapitulated in T reg cells
from mice in which MHCII was deleted in LECs, suggesting an
implication of the autophagy pathway in LECs in MHCII-
restricted Ag-presenting LEC functions. Furthermore, the de-
crease in T reg cell proliferation, which occurs in both Atg5ΔProx1
and MHCIIΔProx1 mice, is another hallmark of T reg cell dys-
function. Indeed, the proliferative rate of T reg cells is increased
during the autoimmune insult and support their suppressive
functions (Attridge and Walker, 2014).
However, whereas LN T reg cells exhibit impaired suppres-
sive functions in mice lacking MHCII expression by LECs, this
was not the case in mice with conditional deletion of autophagy
in LECs. Therefore, additional autophagy-independent pathways
of MHCII-mediated Ag presentation are active in LECs during
CIA and maintain T reg suppressive functions. In particular, in
the absence of autophagy, compensatory intracellular degrada-
tion pathways are activated and can function as an alternative
source of endogenous MHCII Ags, among them chaperone-
mediated autophagy (Wang and Muller, 2015). In parallel,
LECs can capture and process exogenous Ags (Kedl and
Tamburini, 2015; Tamburini et al., 2014; Hirosue et al., 2014).
In vivo, the expression of the integrin CD103 by LN T reg cells is
decreased in mice in which MHCII or autophagy is abrogated in
LECs. CD103 is important for T reg cell retention in inflamed
sites through interaction with the E-cadherin expressed by
other cells, including synoviocytes (Agace et al., 2000; Luan
et al., 2018). Accordingly, decreased CD103 expression has
been correlated to an impaired ability of T reg cells to localize at
the site of infection and to dampen inflammation, while their
intrinsic suppressive functions remained unchanged (Suffia
et al., 2005). Therefore, the decrease of CD103 expression by
T reg cells observed during CIA after the deletion of either
autophagy or MHCII in LECs may impair their abilities to
regulate self-reactive effector T cells in inflamed knees. Ac-
cordingly, we observed altered CD103 expression by T reg cells
in arthritic joints of mice lacking autophagy in LECs.
Our data show that both autophagy and MHCII deletion in
LECs result in T reg cell alterations. Future experiments will
establish whether a direct link exists between these two path-
ways in LECs. Analyzing the MHCII peptide repertoire of LECs
could in particular unravel the contribution of autophagy to
their peptidome. However, limited numbers of LECs ex vivo will
make such studies challenging.
Apart from their Ag-presenting functions, another way
among others for LECs to control immune responses is to reg-
ulate lymphocyte trafficking. During CIA or after OVAII immu-
nization, Th17 cells but not Th1 cells were decreased in LNs from
mice inwhich LECs cannot induce autophagy. This effect further
correlates with enhanced Th17 accumulation in inflamed joints,
demonstrating an aberrant migratory pattern of Th17 in CIA
when LECs are deficient for autophagy. Interestingly, we iden-
tified LN Th17 cells as high expressors of S1P1, the receptor
implicated in effector T cell egress (Garris et al., 2014), compared
with Th1 and T reg cells, indicating differences in S1P sensitivity
between distinct effector T cell subsets. Supporting our in vivo
data, in vitro Th1 and Th17 cell migration assays toward S1P
gradients revealed an increased Th17 migration (three- to
fourfold change) compared with Th1 (twofold change; Seki et al.,
2010). Consistently, studies have shown that S1P1 over-
expression in T cells promotes Th17 differentiation (Lee et al.,
2010; Huang et al., 2007).
The fact that autophagy in LECs regulates Th17 egress from
LNs during CIA deepens our understanding of disease progres-
sion. CIA is a Th17-dependent disease, and treatment with
anti–IL-17–depleting antibodies strongly dampens disease se-
verity (Park et al., 2012). In agreement, we show that a dysre-
gulation of Th17 effector cell trafficking significantly exacerbates
the CIA clinical symptoms.
In addition to playing a role in Ag presentation, autophagy
has also been shown to be implicated in lipid metabolism, in
particular sphingolipids such as ceramide and sphingosine
(Ki67+; B) in the CD4+ T cell population. (C and D) CD103 frequencies (C) and median (D) among T reg cells (CD4+FoxP3+; C) and CD103+ T reg cells
(CD4+FoxP3+CD103+; D), CD25 negative (neg), or expressing low or high levels of CD25 in dLNs at days 26 and 31. Data are representative of two experiments
with five or six mice/group each. (E) FoxP3+ frequency among CD4+ T cells and CD103 expression levels (median) among FoxP3+CD4+ T cells at day 31. Data are
from one experiment with four or five mice/group. Unpaired t test (A and B) and two-way ANOVA (C and D). * P < 0.05, ** P < 0.01, and *** P < 0.001.
(A–E) Error bars correspond to lower and higher values for each group.
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(Alexaki et al., 2014). Although S1P metabolism has been de-
scribed as inducing autophagy (Mitroi et al., 2017), a potential
regulation of S1P production by the autophagy pathway has
not been reported so far. Previous studies revealed that the
accumulation of sphingolipids in cells deficient for autophagy
was due to the gathering of different enzymes implicated in
their metabolism, such as the serine palmitoyltransferase (SPT)
catalyzing the condensation of serine and palmitoyl-CoA, the
Figure 7. Abolition of MHCII but not autophagy in LECs impairs intrinsic T reg cell suppressive functions during CIA. (A) CIA was induced in Tx-treated
MHCIIWT and MHCIIΔProx1 or Atg5WT and Atg5ΔProx1 mice. FoxP3+ and FoxP3− frequencies among CD4+ T cells as well as FoxP3 expression levels (median)
among T reg cells (CD4+FoxP3+), CD25 negative (neg), or T reg cells expressing low or high levels of CD25 were assessed in dLNs from Tx-treated Atg5WT and
Atg5ΔProx1 mice and MHCIIWT and MHCIIΔProx1 mice at late time point after CIA induction (day 50 and day 41, respectively). (B) CIA was induced in Tx-treated
FoxP3RFPRORγtGFP→Atg5ΔProx1, Atg5WT, MHCIIΔProx1, and MHCIIWT BM-chimeric mice. T reg cells (FoxP3RFP) were sorted at day 26 and co-cultured at indicated
ratio with CTV-labeled CD4+CD25neg cells stimulated with anti-CD3 antibodies and BM-derived DCs. After 3 d, the division index of CTV-labeled CD4+CD25neg
cells was analyzed by flow cytometry. (A and B)Data are representative of two independents experiments, six or seven mice/group. (C and D) CIA was induced
in Tx-treated Atg5WT and Atg5ΔProx1 mice and treated or not treated with depleting anti-CD25 antibodies. (C) CD4+FoxP3+ cell depletion was assessed in blood
by flow cytometry at day 25. (D) Clinical scores (paw thickness) were assessed at indicated time points, six mice/group. Multiple t test comparison corrected
using Sidak-Bonferroni method for T reg cell frequencies and two-way ANOVA for median of FoxP3 (A), two-way ANOVA (B and D), and unpaired t test (C).
* P < 0.05, ** P < 0.01, and *** P < 0.001. Error bars correspond to lower and higher values for each group (A and C) and to SEM (B and D).
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Figure 8. Abolition of autophagy in LECs alters Th17 in dLNs during early phases of CIA. (A and B) CIA was induced in Tx-treated Atg5WT and Atg5ΔProx1
mice (A) and Tx-treated MHCIIWT and MHCIIΔProx1 mice (B), and IFN-γ–producing CD4+ T cell (Th1) and IL-17–producing CD4+ T cell (Th17) frequencies were
analyzed in dLNs at indicated time points. (C–E) Tx-treated Atg5WT and Atg5ΔProx1 CIA mice were injected with FTY-720 (C). (D and E) At day 31, IFN-
γ–producing (Th1) and IL-17–producing (Th17; D), total T reg (FoxP3+) and CD103+ T reg (CD103+Foxp3+; E) CD4+ T cell frequencies were analyzed in dLNs by
flow cytometry. Data are representative of two independent experiments with five to seven mice/group. (F) Expression levels of type 1 receptor of S1P (S1P1
median) were assessed by flow cytometry on T reg (FoxP3+), Th1 (IFN-γ+), and Th17 (IL-17+) CD4+ cells from dLNs of CIA WT mice at day 31. Data are
representative of two independent experiments with four or five mice/group. Unpaired t test (A and B), multiple t test comparison corrected using the Sidak-
Bonferroni method (D and E), and one-way ANOVA (F). * P < 0.05, ** P < 0.01, and *** P < 0.001. (A–F) Error bars correspond to lower and higher values for
each group.
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Figure 9. Autophagy controls LEC ability to regulate effector T cell migration by inducing SphK1 degradation and decreasing S1P production. (A–C)
Tx-treated Atg5WT and Atg5ΔProx1 mice were immunized with OVAII/CFA. 5 d later, IFN-γ–producing (Th1), IL-17–producing (Th17) CD4+ T cell frequencies (A),
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first step to convert ceramide toward sphingosine (Alexaki et al.,
2014; Havé et al., 2019). SPT can be degraded by autophagy in
hepatocytes, whereas autophagy inhibition led to intracellular
SPT accumulation (Alexaki et al., 2014). In agreement with these
studies, we show that SphK1 and SphK2, two enzymes impli-
cated in sphingolipid metabolism and precisely in S1P produc-
tion, exhibit predictive LC3-interacting domains, suggesting that
they might be actively degraded by the autophagy pathway.
Furthermore, SphK1 displays a high LC3-interacting motif PSSM
score, predicting its efficient targeting toward autophagosomes.
Accordingly, we observed that SphK1, but not SphK2, is regu-
lated by autophagy, which is not surprising also considering the
localization of the two enzymes. SphK1 is located in the cyto-
plasm, allowing potential interactions with LC3 proteins. In
contrast, SphK2 is preferentially contained in the nucleus and
other intracellular organelles (Wattenberg, 2010; Siow et al.,
2010). Although only SphK1 protein turnover can be regulated
by autophagy, disruption of this pathway is sufficient to sig-
nificantly inhibit SphK1 protein degradation and increase S1P
production by LECs. In agreement, it has been shown that SphK1
deletion in mice significantly decreases the S1P gradient in
blood, altering lymphocyte trafficking (Adamiak et al., 2017). In
contrast, SphK2 deficiency results in an augmented circulating
S1P gradient, likely due to either a compensatory effect by SphK1
or an increased S1P stabilization (Adamiak et al., 2017). Ac-
cordingly, autophagy deficiency stabilizes/accumulates SphK1 in-
tracellular levels, leading to an increase of S1P production by LECs.
In addition, SphK2 mRNA expression levels in LECs were not af-
fected by the deletion of autophagy, indicating that the increase of
S1P production by autophagy-deficient LECs is not a consequence
of decreased SphK2 levels as described in SphK2-deficient mice
(Adamiak et al., 2017). Interestingly, while the injection of SphK2-
specific siRNAs in mice does not impact CIA, mice that received
specific SphK1 siRNA developed attenuated CIA (Lai et al., 2009).
Our data demonstrate that in inflammatory conditions such as
CIA, autophagy induction in LN LECs promotes SphK1 degrada-
tion, leading to reduced S1P production in LNs and limited Th17
cell exit, and finally to dampened disease development.
Relevant for our study, mice deficient for Spns2 (Spinster
homologue 2) exhibit reduced disease severity in several in-
flammation and autoimmune mouse models, such as experi-
mental autoimmune encephalomyelitis, CIA, colitis, or airway
inflammation (Donoviel et al., 2015). LECs are well described as
the main source of S1P in LNs and regulate lymphocyte exit from
LNs toward the periphery (Pham et al., 2010). Several LEC
subsets were recently defined within the LNs, and one particular
subset localized in the paracortical sinus close to the medulla
expresses elevated levels of Spns2 (Fujimoto et al., 2020). Spns2
is a transporter expressed by LECs, required for S1P release in
the lymph (Mendoza et al., 2012). Because of their localization
and their enhanced ability to generate S1P gradient, this specific
LEC subset may play a major role for lymphocyte egress from
LNs. Future investigations will determine how autophagy is
regulated in this particular subset and how it affects S1P pro-
duction and effector T cell egress under pathological conditions.
LECs in skin lymphatic vessels can also produce S1P (Petrova and
Koh, 2018).
In conclusion, we show that in CIA, T reg (including CD103+ T
reg cells) and Th17 cells are altered in LNs from mice lacking
autophagy in LECs. However, the way autophagy in LEC regulates
these two cellular components is likely to be different. S1P-blocking
experiments demonstrate that the priming of T reg cells is impacted
by the loss of autophagy in LECs. These results argue for a local role
of autophagy in LECs in regulating T reg cells in LNs during CIA. In
contrast, whereas Th17 cells in LNs from CIA Atg5ΔProx1 mice are
decreased compared with control mice, the difference is abolished
upon S1P blockade, indicating a role for autophagy in LECs in
modulating Th17 cell exit from LNs and not their priming. Specif-
ically, the effect on Th17 cell homing is related to the regulation of
S1P production by autophagy in LECs. Regarding the latter mech-
anism, it is difficult to decipher the contribution of LECs in lym-
phatic vessels and LN LECs in our conditional knockout mice, in
which LECs from both compartments were deleted for autophagy.
Both lymphatic vessel and LN LECs can produce S1P and may
possibly be modulated by autophagy. The possible regulation of the
pathway by autophagy in LECs from one or the other compartment
nevertheless brings new insight into the role of LECs in dampening
T cell–mediated inflammatory diseases bymodulating effector T cell
egress from LNs and migration in inflamed tissues. The identifi-
cation of autophagy as a crucial modulator of S1P production by
LECs might be considered as a novel way to modulate unwanted
T cell responses under inflammatory conditions.
Materials and methods
Mice
WT mice (Charles River), OT2 (Barnden et al., 1998),
ProxCreERT2 (from T. Makinen, Uppsala University, Uppsala,
Foxp3+ (T reg cell) CD4+ T cell frequencies (B), and S1P1 expression levels (median) in T reg, Th1, and Th17 cells (C) were determined by flow cytometry. Data
are representative of two independent experiments with five or six mice/group. (D) Tx-treated Atg5WT and Atg5ΔProx1 mice were adoptively transferred with
RORγtGFPFoxP3RFP OT-II T cells and immunized with OVAII/CFA the day after. 5 d later, distances between RORγt-GFP+ Th17 cells and Lyve1+ LECs were
calculated on LN sections, four or five mice/group. (E) SphK1, SphK2, and autophagosome (LC3-GFP+ organelles) staining in LECs sorted from LC3-GFP mice
cultured and starved or not in HBSS+CQ for 4 h. Data are representative of three independent experiments with two or three mice/group. (F) SphK1 protein
levels and LC3-II/LC3-I ratios (fold change) on sorted LECs from Tx-treated Atg5WT and Atg5ΔProx1 mice, cultured and starved or not for 4 h. Data are rep-
resentative of three independent experiments with two or three mice/group. (G) LECs sorted from Tx-treated Atg5WT and Atg5ΔProx1 mice were cultured in the
bottom part of a transwell membrane and starved or not for 16 h. Activated CD4+ T cells, treated or not treated with FTY-720, were added in the upper part.
After 4 h, CD4+ T cell transmigration was analyzed by flow cytometry in the bottom part. Results are expressed as the ratio of migrated CD4+ T cells normalized
to the control group (nonstarvedWT LECs without FTY-720). Data are representative of three independent experiments with three or four mice/group. (H) S1P
quantification (ELISA) from sorted Tx-treated Atg5WT and Atg5ΔProx1 LECs cultured in RPMI with 1% of BSA (FBS free) for 48 h (two independent experiments
with five or six mice/group). Unpaired t test (A, B, and H), one-way ANOVA (C, F, and G), and Kruskal Wallis (D). * P < 0.05, ** P < 0.01, and *** P < 0.001. Error
bars correspond to lower and higher values for each group (A–D, F, and H) and to SEM (G).
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Sweden; Bazigou et al., 2011) crossed with MHCIIf/f
(MHCIIΔProx-1; Dubrot et al., 2018), LC3-GFP (from N. Miz-
ushima, University of Tokyo, Tokyo, Japan; Mizushima et al.,
2004), Flt4creERT2 (from S. Ortega, Spanish National Cancer
Research Center, Madrid, Spain; Stanczuk et al., 2015), and
Foxp3RFPRORγtGFP (from M. Lochner, Institute for Medical
Microbiology and Hospital Epidemiology, Hannover Med-
ical School, Hanover, Germany; Yang et al., 2016) mice were
used between the ages of 8 and 12 wk. All mice had a pure
C57BL/6 background and were bred and maintained under
specific pathogen–free conditions at the animal facility of
Geneva Medical School and at Charles River in France. All
procedures were approved and performed in accordance
with the guidelines of the animal research committee of
Geneva. ProxCreERT2Atg5f/f (Atg5ΔProx-1), Flt4creERT2Atg5f/f
(Atg5ΔFlt4), Atg5f/f control (Atg5WT), ProxCreERT2MHCIIf/f
(MHCIIΔProx-1), and MHCIIf/f control (MHCIIWT) mice were
treated i.p. with Tx (T5648; Sigma-Aldrich), 1 mg/mouse
twice a day for 4 d. All procedures were performed 2 wk after
the last Tx injection.
CIA
CIA was induced in C57BL/6 mice by using an adapted protocol
based on previous publication (Inglis et al., 2008). Briefly, an
emulsion of chicken type II collagen (Col2, 4 mg/ml; Chondrex)
and CFA (4 mg/ml; BD Bioscience) was injected i.d. at days 0 and
21 (boost injection) at the base of the tail (50 µl) and 1 cm upper
in the back (50 µl). Paw thickness was measured using a caliper,
and weights were followed once a week up to day 21 and then
every 1–2 d from day 21. Caliper measures were used to deter-
mine clinical scores (normalized to day 0 for each mice). Scores
from 0 to 3 (0: no inflammation; 1: slight swelling; 2: pronounced
swelling; 3: ankylosis) were attributed for each paw, and clinical
scores represent the sum of the scores for the four paws. For
histological analysis, knees were fixed in 4% paraformaldehyde
(PFA) for 24 h and decalcified in Tris-EDTA buffer for 6 wk.
After paraffin embedment, 5-µm sections were stained either
with hematoxylin and eosin or with toluidine blue and blind
graded. Histological analysis (scores from 0 to 3) was deter-
mined for each knee based on inflammation levels. Global in-
flammation scores represent the sum of the scores of two knees
for each mouse. At least three sections per knee were examined
to ensure extensive evaluation of the arthritic joints. The lesions
were blindly evaluated for each joint as previously described
using a four-point scale (0–3, where 0 is normal and 3 is severe;
Biton et al., 2016; Clavel et al., 2006). This global histological
score reflects both synovitis (synovial proliferation, inflamma-
tory cell infiltration) and joint destruction (bone and cartilage
thickness and irregularity and presence of erosions). We also
separately evaluated articular destruction by considering the
degradation of bone and cartilage regardless of inflammation on
a four-point scale (0–3, where 0 is no destruction and 3 is the
presence of subchondral bone erosions).
In some CIA experiments, FTY-720 (20 µg/mice; Sigma-Al-
drich) was injected i.p. every 2 d from day 20 to day 30. For some
other CIA experiments, anti-CD25–depleting antibody (100 µg/
mice; Bioxcell) was injected i.p. every 3 d from day 19 to day 40.
OVAII immunization
Mice were immunized with an emulsion of CFA and OVAII
peptide (ISQAVHAAHAEINEAGR, 25 µg/50 µl; PolyPeptide) s.c.
in each flank. 5 d later, cells from dLNs were isolated for FACS
analysis.
For LN histology, Atg5ΔProx1 and Atg5WT mice were in-
jected i.v. with 106 naive CD4+ T cells isolated from OT-II/
Foxp3RFPRORγtGFP mice and immunized 24 h later with OVAII
peptide emulsified in CFA (as described previously). 5 d after
immunization, dLNs were frozen, and 5-µm-thick sections
were fixed in PFA 4% at room temperature (RT) during 20 min.
After washing, samples were permeabilized with Triton X-100
(1/400e) and blocked with normal goat serum (1/100e) for
30 min at RT and Triton X-100 (1/800e) for another 30 min at
RT. Staining was performed overnight at 4°C using primary
anti-GFP (1/1,000e; Thermo Fisher Scientific) and anti-Lyve1
(1/200e) antibodies. After washing, secondary antibodies
against chicken Alexa Fluor 488 for GFP staining and anti-
rabbit Alexa Fluor 546 (1/1,000e; Thermo Fisher Scientific)
were used for 2 h at RT (in the dark). Samples were washed and
stained for 5 min with DAPI. Pictures were acquired using a
confocal microscope (LSM700; Zeiss). Distances between LECs
(Lyve-1+ cells) and CD4+ OT-II Th17 cells (RORγt-GFP+ cells)
were blinded and calculated using ImageJ software.
Cell isolation
dLNs were cut into small pieces and digested in RPMI containing
1 mg/ml collagenase IV (Worthington Biochemical Corporation),
40 µg/ml DNase I (Roche), and 2% FBS for 30 min at 37°C. Re-
maining tissue pieces were further digested with 1 mg/ml col-
lagenase D and 40 µg/ml DNase I (Roche) and 1% of FBS for
20min at 37°C. The reaction was stopped by adding 5mMEDTA
and 10% BSA. Samples were further disaggregated through a
70-µm cell strainer, and Fc receptors were blocked with anti-
CD16/32 antibody. For LNSC analysis, single-cell suspensions
were magnetically enriched in CD45neg cells by using CD45
microbeads (Miltenyi Biotec) according to the manufacturer’s
instructions.
To assess joint infiltrating T cells, posterior legs from CIA
mice were dissected. Muscles and skin were totally removed
from the legs and paws, and femurswere dissociated from tibias.
Full bones (femurs and tibia with paws) were digested in 5 ml of
RPMI containing 1 mg/ml of collagenase A and 40 µg/ml of
DNase I for 45 min at 37°C under gentle agitation. The reaction
was stopped by adding 5 mM EDTA and 10% BSA, and cell sus-
pensions were filtered (70 µm). A percoll 70–40% at 700 g for
25 min at RT was performed, and the cells at the interface be-
tween percoll 70% and 40% were harvested for flow cytometry
analysis.
In vitro suppression assay
2 wk after Tx treatment, mice were irradiated twice a day
(500 mGy). The day after irradiation, 5 × 106 BM cells from
Foxp3RFPRORγtGFP mice were injected (i.v.), and the mice re-
ceived antibiotics in water for the next 2 wk. CIA was induced in
BM chimeric mice after 8 wk, and T reg cells from dLNs were
sorted (based on RFP expression) after 26 d with Aria sorter (BD
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Bioscience). T reg cells were co-cultured at different ratios with
purified CTV-labeled naive CD25negCD4+ T cells (magnetic beads
isolation kit; Miltenyi Biotec) stimulated with anti-CD3 antibody
(0.25 µg/ml; eBioscience), and BM-derived DCs were differen-
tiated during 9 d with GM-CSF as described previously (Lippens
et al., 2018). 3 d after, naive T cell proliferation was assessed by
flow cytometry, and the proliferation index was calculated using
FlowJo software. The division index (FlowJo software) provides
the average number of cell divisions that a cell in the original
population has undergone. This is an average even for cells that
never divided (i.e., it includes the undivided peak).
Stromal cell cultures
LEC and FRC cultures were performed as previously described
(Fletcher et al., 2010). Briefly, LNs from one to three mice were
dissected and digested with a freshly made enzymatic solution
composed of RPMI-1640 containing 0.8 mg/ml Dispase, 0.2 mg/
ml Collagenase P, and 0.1 mg/ml DNase I (Roche). Tubes were
incubated at 37°C in a water bath and gently inverted at 10-min
intervals to ensure the contents were mixed. Every 10 min, LNs
were very gently mixed using a 1-ml pipette. Large fragments
were allowed to settle before replacing the supernatant for fresh
digestion mix. Supernatant containing the cells was kept in cold
FACS buffer (2% FCS, 0.5% BSA, and 5 mM EDTA in PBS). These
steps were repeated every 10 min until complete digestion. Cells
were washed, filtered (70 µm), and incubated in 6-well plates
coated with human fibronectin and collagen for 30 min at 37°C
at the concentration of 7 × 106 cells/well in MEM supplemented
with 10% batch-tested, low-Ig FCS and 1% penicillin/strepto-
mycin. Plates were washed, and culture medium was renewed
every day to remove nonadherent CD45+ cells. After 5 d, cultures
primarily contained a mixture of LECs and FRCs. Autophago-
some formation was assessed in LECs and FRCs sorted from LC3-
GFP mice, cultured, and stimulated with either IFN-γ (1 µg/ml)
or CQ (50 µM) for 24 h. Then, organelle formation (LC3-GFP+)
was determined following LC3 relocalization into the cells.
Western blot
After stromal cell culture using LNs from Atg5ΔProx1 and Atg5WT
mice, LECs were sorted by flow cytometry (Astrios sorter;
Beckman Coulter) and cultured (100,000 cells/well) in 12-well
plates coated as before. At cell confluence, LECs were starved
(HBSS) for 4 h to induce autophagy. Proteins from LECs (starved
or not) were extracted using a lysis buffer (Tris, pH 8, 150 mM,
NaCl 50 mM, and 1% NP-40) with protease inhibitor (Millipore).
Proteins were quantified, and 5 µg was warmed at 95°C for
5 min and migrated onto a 12% SDS-acrylamide gel. After
transfer on a polyvinylidene difluoride membrane, a saturation
step was performed with PBS containing 5% milk for 1 h at RT,
and anti-LC3 (1/2,000e; Cell Signaling) or anti-SphK1 (1/1,000e;
BIOSS USA) antibodies were incubated overnight at 4°C under
agitation. After washing, the membrane was incubated with
secondary antibodies, goat anti-rabbit–HRP (1/10,000e; Bio-
Rad), or anti-mouse–HRP (1/5,000e; Santa Cruz) for 1 h at RT,
and the HRP substrate (Millipore) was used to reveal the pro-
teins. Protein expression levels were normalized to GAPDH
control protein expression level.
Human iLECs (provided by T. Petrova, University of Lau-
sanne, Lausanne, Switzerland; Norrmén et al., 2010) were
seeded in a 12-well plate coated with human fibronectin in EGM-
2 medium (Lonza; Ruwag) at a concentration of 100,000 cells in
2 ml medium. At confluence, cells were starved in HBSS for 4 h,
and Western blots were performed as described above.
In vitro transmigration assay
LECs were sorted by flow cytometry (Astrios sorter; Beckman
Coulter) from Atg5ΔProx1 and Atg5WT stromal cell cultures and
incubated (100,000 LECs/well) in 24-well plates coated as be-
fore. At cell confluence, cells were starved (in HBSS) or not
starved overnight (250 µl). LEC culture medium was supple-
mented with 600 µl of RPMI, and transwell membrane (5-µm
pores; Cornix) was added in each well. CD4+ T cells were puri-
fied from naive mice using a magnetic isolation kit (Miltenyi
Biotec) and activated in vitro (anti-CD3 + anti-CD28 antibodies) for
3 d. Then, activated CD4+ cells were treated or not with FTY-720
(100 nM; Sigma-Aldrich) for the last 12 h, washed, and added
(150,000 cells) in the upper part of the transwell. 4 h later, CD4+
T cell migration was analyzed in the bottom part by flow cytometry
using counting beads (BD Bioscience). Results are expressed as ratio
of CD4+ T cell migration compared with control group (unstarved
Atg5WT LECs with CD4+ T cells untreated with FTY-720).
S1P ELISA
LECs were sorted by flow cytometry (Astrios sorter; Beckman
Coulter) from LEC/FRC cultures of Atg5ΔProx1 and Atg5WT LNs,
and 100,000 cells/well were seeded in 12-well plates coated as
before. At confluence, LECs were washed in PBS and cultured in
RPMI (FBS free) containing 1% penicillin/streptomycin and 1%
BSA. After 48 h, supernatants were harvested and centrifuged at
10,000 g for 10min to eliminate cell debris. Quantification of S1P
in supernatants was performed using the General Sphingosine-
1-Phosphate (S1P) ELISA kit (MyBioSource) according to the
manufacturer’s instructions.
LIR database analysis
For each protein, amino acid sequences were analyzed using a
published iLIR database (Nezis, 2021) to obtain predictive LIRs
and their PSSM scores. Predictive LIRs with PSSM scores >12
give reliable prediction for targeting protein toward autopha-
gosomes (with an accuracy >75.4% and sensitivity >88.9%;
Kalvari et al., 2014).
Flow cytometry
Anti-CD45 (30-F11), anti-gp38 (8.1.1) and anti-CD31 (390), anti-
CD8 (53–6.7), anti-CD25 (PC61), FoxP3 (FJK-16S), anti-Ki67
(SolA15), anti-IL-17 (eBio17B7), and anti–IFN-γ (XMG1.2) were
from eBioscience and/or Invitrogen. Anti-TCRb (H57-597), anti-
CD4 (GK1.5), anti–I-Ad/I-Ed (2G9), and anti-CD103 (M290) were
from BD Bioscience, and anti-S1P1 (FAB7089P) was from R&D
Systems. LC3 staining was performed using the “Flowcellect
Autophagy LC3 Antibody-based assay kit” (FCCH100171; Milli-
pore) according to the manufacturer’s instructions.
For LNSC flow cytometry sorting, ex vivo–enriched CD45neg
LN cells or LEC/FRC cultures were stained with antibodies
Harlé et al. Journal of Experimental Medicine 19 of 24
Autophagy in LECs inhibits CIA https://doi.org/10.1084/jem.20201776
against CD45, gp38, and CD31, and cells were sorted using an
Astrios (Beckman Coulter).
For intracellular cytokine staining, cells were stimulated for
4 h in vitro with PMA/ionomycin (Sigma-Aldrich) and GolgiPlug
(BD Bioscience) in RPMI containing 10% heat-inactivated FBS,
50 mM 2-mercaptoethanol, 100 mM sodium pyruvate, and
100 µM penicillin/streptomycin at 37°C and 5% CO2. FoxP3, IL-
17, and IFN-γ were stained using fixation/permeabilization
buffer (eBioscience) according to the manufacturer’s instructions.
Cells were acquired on Fortessa (BD Bioscience), and analysis was
performed using FlowJo software.
Immunofluorescence
Staining for autophagosomes and MHCII
LC3-GFP mice were injected s.c. with IFN-γ (1 µg/ml) and with
CQ 24 h later (50 µM) in both flanks and neck area or immu-
nized for CIA. Stromal cells (LECs, BECs, and FRCs) from dLNs
were sorted (Astrios; Beckman Coulter) after 24 h. Sorted cells
were cytospined and fixed in acetone at −20°C for 20 min. After
washing, samples were permeabilized with Triton X-100
(1/400e) and blocked with normal goat serum (1/100e) for
30 min at RT and Triton X-100 (1/800e) for another 30 min at
RT. Staining was performed overnight at 4°C using primary anti-
GFP (1/1,000e; Thermo Fisher Scientific) and anti–MHC-II bio-
tinylated (1/200e) in some experiments. After washing, secondary
antibodies against chicken Alexa Fluor 488 for GFP staining and
streptavidin Alexa Fluor 546 for MHCII detection (1/300e; eBio-
science) were incubated for 2 h at RT (in the dark).
Staining for SphK and autophagosomes
LECs sorted from LNs of LC3-GFP mice were starved (HBSS,
devoid of FBS) and treated with CQ (50 µM) for 4 h to induce and
stabilize autophagosomes. Then, LECs were fixed in PFA 4% at RT
for 20 min. After washing, samples were permeabilized with
Triton X-100 (1/400e) and blocked with normal goat serum
(1/100e) for 30 min at RT and with Triton X-100 (1/800e) for
another 30 min at RT. Staining was performed overnight at 4°C
using primary anti-GFP (1/1,000e; Thermo Fisher Scientific) and
anti-SphK1 or anti-SphK2 (1/200e; Bioss USA) antibodies. After
washing, secondary antibodies against chicken Alexa Fluor 488 for
GFP staining and anti-rabbit Alexa Fluor 546 (1/1,000e; Thermo
Fisher Scientific) were incubated for 2 h at RT (in the dark).
Staining of lymphatic vessels in skin and LNs
Tissues were harvested and frozen 5 d after OVA + CFA im-
munization, and 5-µm-thick sections were fixed in PFA 4% at RT
during 20 min. Staining was performed as described previously
with anti-Lyve1 antibody (1/400e). After washing, secondary
anti-rabbit Alexa Fluor 546 antibody (1/1,000e; Thermo Fisher
Scientific) was incubated for 2 h at RT (in the dark).
In all cases, samples were washed and stained for 5 min with
DAPI. Pictures were acquired using a confocal microscope
(LSM700; Zeiss).
Staining of T and B cell zones in LNs
Skin LNs were harvested and frozen 2 mo after Tx treatment. 5-
µm-thick sections were fixed in PFA 4% at RT during 20 min.
After washing, samples were permeabilized with Triton X-100
(1/400e) and blocked with normal goat serum (1/100e) for
30min at RT and with Triton X-100 (1/800e) for another 30min
at RT. Staining was performed overnight at 4°C using anti–
B220–Alexa Fluor 488 (eBioscience clone RA3-6B2, coupled to
Alexa Fluor 488 1/50e) and anti-CD3 Alexa Fluor 647 (clone 145-
2C11, 1/100e; Biolegend) antibodies. After washing and staining
for 5 min with DAPI, pictures were acquired using an upright
spinning disk confocal microscope (Axio Examiner Z1 Advanced
Microscope Base; Zeiss) equipped with a confocal scanner unit
CSU-X1 A1 (Yokogawa Electric Corporation). The fluorescence
was detected with an electron-multiplying charge-coupled de-
vice camera (Evolve 512 10 MHz Back Illuminated; Photo-
metrics) and a 10×/0.3 numerical aperture water immersion
objective (W Plan Apochromat; Zeiss) using three lasers with the
excitation wavelengths of 405 nm, 488 nm, and 640 nm (La-
serStack v4 Base, 3i) and appropriate band-pass-emission filters
(Semrock). Three-dimensional image stacks were obtained by
sequential acquisition of multiple fields of views along the z axis
using a motorized XY-stage (ProScan; Prior). SlideBook software
(6.0.17, 3i) was used for image acquisition, and the subsequent
deconvolution, creation of maximum projection, and generation
of montage images from contiguous positions were performed
using the Fiji plugins Deconvolutionlab2 and grid/collection
stitching (Sage et al., 2017; Preibisch et al., 2009).
Lymphatic vessel drainage
5 d after OVA + CFA immunization (s.c., tail base), dextran–
Alexa Fluor 488 (40 kD) was injected in the left footpad (50 µl at
5 mg/ml). 30 min later, dLNs (popliteal and inguinal) from the
left side and their ipsilateral control from the right side were
harvested and dissociated in 200 µl of PBS. A fluorospec-
trometer (Spectamax Paradigm; Molecular Devices) was used to
determine Alexa Fluor 488 fluorescence intensity in dLNs.
Background of fluorescence in the ipsilateral side was removed
to the intensity of the dextran–Alexa Fluor 488 left side.
Quantitative RT-PCR
Total RNA was isolated using RNeasy kit (Qiagen) for LECs,
BECs, and FRCs from different samples. For mRNA extraction
from paws and dLNs, a homogenizer (Polytron) was used to
dissociate the tissues in Tri-Reagent (Ambien). cDNA was syn-
thesized using random hexamers and M-MLV reverse tran-
scription (Promega). PCRs for cDNAs were performed with the
CFX Connect real-time PCR detection system and iQ SYBR green
super mix (Bio-Rad Laboratories). Results were normalized to
GAPDH cDNA expression level.
Primer sequences: Gpa-A33, F: 59-CCGAAGTCAGACGGAAAG
AG-39 and R: 59-TGCTGGAGGTGCAGATGTAG-39; PLP, F: 59-CAG
GGGGCCAGAAGGGGAGG-39 and R: 59-GCAGCCCCACAAACG
CAGC-39; Tyr, F: 59-GCCCAGCATCCTTCTTC-39 and R: 59-TAG
TGGTCCCTCAGGTGTTC-39; NTS, F: 59-CAGCTCCTGGAGTCT
GTGCT-39 and R: 59-GAGTATGTAGGGCCTTCTGGG-39; Amy2, F:
59-TGGCGTCAAATCAGGAACATG-39 and R: 59-AAAGTGGCT
GACAAAGCCCAG-39; SEMA3D, F: 59-GACCATGTTGTTTCTTCC
AGTCA-39 and R: 59-CAGTCCTTCTGATGAACCCAAA-39; col2a1,
F: 59-CATTGTTGGTCTGCCTGGTC-39 and R: 59-TCTCACCACGAT
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CTCCCTTG-39; SphK1, F: 59-CTCCTGGGCAACACCGATAA-39 and
R: 59-ATGGTTCTTCCGTTCGGTGA-39; SphK2, F: 59-ACAGAC
AGAACGACAGAACCA-39 and R: 59-CAGGTCAACACCGACAAC
CT-39; SPGL1, F: 59-AGCTCCATGGATGGTTCCTG-39 and R: 59-
TAACGCCAAGTCCCGGTAAG-39; mSAA, F: 59-GTTCACGAGGCT
TTCCAAGGGGCTGG-39 and R: 59-CCTGAAAGGCCTCTGTTCCAT
CACTG-39; IL-6, F: 59-TCTGTATCTCTCTGAAGGACTCTGGCT-39
and R: 59-TCAACAACGATGATGCACTTGCAGA-39; and GAPDH,
F: 59-CCCGTAGACAAAATGGTGAAG-39 and R: 59-AGGTCAATG
AAGGGGTCGTTG-39.
Statistical analysis
Statistical analysis was performed using GraphPad prism soft-
ware. One-way ANOVA, two-way ANOVA, unpaired t test
(Mann-Whitney), Kruskal-Wallis test, or multiple t test com-
parisons corrected with Sidak-Bonferroni method was per-
formed to determine the P value: * for P < 0.05, ** for P < 0.01,
and *** for P < 0.001. For graphs representing violin plots, error
bars correspond to lower and higher values for each group. For
the rest of the analysis (normal histograms, CIA clinical scores,
and T reg cell suppression), error bars correspond to SEM.
Online supplemental material
Fig. S1 shows LN B cell, natural killer, neutrophil, macrophage,
and DC frequencies and their expression levels of the cos-
timulatory molecules CD80 and CD86; B and T cell areas of LN
sections; and LN weights from Atg5ΔProx1 and Atg5ΔWT mice at
steady state. Fig. S2 shows T cell frequencies in secondary
lymphoid organs as well as peripheral tissues at steady state. Fig.
S3 provides T reg cell analysis in dLNs from CIAMHCIIΔProx1 and
MHCIIWT mice at days 26 and 31. Fig. S4 shows lymphatic vessel
organization in dLNs and skin, as well as lymphatic drainage
functions, of Atg5ΔProx1 and Atg5WT mice immunized with OVA/
CFA. Fig. S5 shows the iLIR motifs for SphK1 and SphK2; SphK1,
SphK2, and SPGL1 mRNA expression levels in LN LECs of ar-
thritic Atg5ΔProx1 and Atg5WT mice; the Western blot of LC3-II/I;
SphK1 in iLECs starved or not starved; and the autophagosome
formation (LC3-GFP+ organelles), induced after IFN-γ treatment,
in cultured LECs and their ability to induce T cell transmigration
under inflammatory stimulus (IFN-γ).
Data availability
The data underlying this article are accessible at https://doi.org/
10.26037/yareta:oijq3aigebfctoioe3mgs2s4am.
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Inglis, J.J., E. Šimelyte, F.E. McCann, G. Criado, and R.O. Williams. 2008.
Protocol for the induction of arthritis in C57BL/6 mice. Nat. Protoc. 3:
612–618. https://doi.org/10.1038/nprot.2008.19
Kalvari, I., S. Tsompanis, N.C. Mulakkal, R. Osgood, T. Johansen, I.P. Nezis,
and V.J. Promponas. 2014. iLIR: A web resource for prediction of Atg8-
family interacting proteins. Autophagy. 10:913–925. https://doi.org/10
.4161/auto.28260
Kappos, L., J. Antel, G. Comi, X. Montalban, P. O’Connor, C.H. Polman, T.
Haas, A.A. Korn, G. Karlsson, and E.W. Radue. FTY720 D2201 Study
Group. 2006. Oral fingolimod (FTY720) for relapsing multiple
sclerosis. N. Engl. J. Med. 355:1124–1140. https://doi.org/10.1056/
NEJMoa052643
Kedl, R.M., and B.A. Tamburini. 2015. Antigen archiving by lymph node
stroma: A novel function for the lymphatic endothelium. Eur. J. Immunol.
45:2721–2729. https://doi.org/10.1002/eji.201545739
Klionsky, D.J., K. Abdelmohsen, A. Abe, M.J. Abedin, H. Abeliovich, A. Ace-
vedo Arozena, H. Adachi, C.M. Adams, P.D. Adams, K. Adeli, et al. 2016.
Guidelines for the use and interpretation of assays for monitoring au-
tophagy (3rd edition). Autophagy. 12:1–222. https://doi.org/10.1080/
15548627.2015.1100356
Komatsu, N., M.E. Mariotti-Ferrandiz, Y. Wang, B. Malissen, H. Waldmann,
and S. Hori. 2009. Heterogeneity of natural Foxp3+ T cells: a committed
regulatory T-cell lineage and an uncommitted minor population re-
taining plasticity. Proc. Natl. Acad. Sci. USA. 106:1903–1908. https://doi
.org/10.1073/pnas.0811556106
Lai, W.-Q., A.W. Irwan, H.H. Goh, A.J. Melendez, I.B. McInnes, and B.P.
Leung. 2009. Distinct roles of sphingosine kinase 1 and 2 in murine
collagen-induced arthritis. J. Immunol. 183:2097–2103. https://doi.org/
10.4049/jimmunol.0804376
Lee, J.-W., M. Epardaud, J. Sun, J.E. Becker, A.C. Cheng, A.R. Yonekura, J.K.
Heath, and S.J. Turley. 2007. Peripheral antigen display by lymph node
stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8:
181–190. https://doi.org/10.1038/ni1427
Lee, H., J. Deng, M. Kujawski, C. Yang, Y. Liu, A. Herrmann, M. Kortylewski,
D. Horne, G. Somlo, S. Forman, et al. 2010. STAT3-induced S1PR1 ex-
pression is crucial for persistent STAT3 activation in tumors. Nat. Med.
16:1421–1428. https://doi.org/10.1038/nm.2250
Li, Y., L.X. Wang, P. Pang, C. Twitty, B.A. Fox, S. Aung, W.J. Urba, and H.-M.
Hu. 2009. Cross-presentation of tumor associated antigens through
tumor-derived autophagosomes. Autophagy. 5:576–577. https://doi.org/
10.4161/auto.5.4.8366
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Figure S1. Autophagy abrogation in LECs does not impair LN immune cell frequencies or LN organization at steady state. Atg5WT and Atg5ΔProx1 mice
were treated with Tx. (A) B cells (CD19+), natural killer cells (NK1.1+), neutrophils (Ly6G+), macrophages (F4/80+), M1 (F4/80+CD11ChighCD206low), M2 (F4/
80+CD11clowCD206high macrophages, resident (CD11clowMHCIIhigh), and migratory (CD11chighMHCIIlow) DC gating strategy and frequencies and expression
levels of CD80 and CD86 in skin LNs 2 mo after Tx treatment. Unpaired t test, three or four mice/group. Error bars correspond to lower and higher values for
each group. (B) T cell area (CD3+ cells) and B cell area (B220+ cells) in LNs 2 mo after Tx. Images are representative LNs from three independent mice/group.
(C) Individual peripheral skin LN (Ing., inguinal; Ax., axial; Br., brachial; s1Cer. and s2Cer., superficial cervical 1 and 2; Pool) weights 2 mo after Tx treatment (four
mice/group). Error bars correspond to SEM.
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Figure S2. Autophagy abolition in LECs does not impair LN organization and T cell homeostasis at steady state. Atg5WT and Atg5ΔProx1 mice were
treated with Tx. (A–D) CD4+, CD8+ T cell, and T reg cell (FoxP3+) frequencies, proliferation (Ki67+), and expression of CD103 among T reg cells (CD4+FoxP3+) in
skin LNs (A), spleen (B), salivary glands (C), and lungs (D) assessed by flow cytometry 2 wk and 2 mo after Tx treatment. (E) Frequencies of CD4+ T cells
producing IFN-γ (Th1) and IL-17 (Th17) in LNs 2 wk (2wk) and 2mo after Tx. Unpaired t test; three or four mice/group. (A–E) Error bars correspond to lower and
higher values for each group.
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Figure S3. Abolition of MHCII in LECs impacts T reg cells during CIA. CIA was induced in Tx-treated MHCIIWT and MHCIIΔProx1 mice, and T reg cells were
analyzed in dLNs at days 26 and 31. (A and B) CD4+Foxp3+ cells (T reg cells) and T conv (CD4+Foxp3−) cell frequencies (A) and proliferation rate (Ki67+; B). (C
and D) CD103 frequencies (C) and median (D) among T reg cells (CD4+FoxP3+; C) and CD103+ T reg cells (CD4+FoxP3+CD103+; D), CD25 negative (neg), or
expressing low or high levels of CD25. Five or six mice/group, two independent experiments. Unpaired t test (A and B) and two-way ANOVA (C and D). * P <
0.05, ** P < 0.01, and *** P < 0.001. (A–D) Error bars correspond to lower and higher values for each group.
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Figure S4. Abolition of autophagy in LECs does not impair lymphatic vessel organization and draining functions upon inflammation. (A–C) Tx-treated
Atg5WT and Atg5ΔProx1 mice were injected with OVA + CFA. 5 d later, lymphatic vessels (Lyve1+) were analyzed on sections from dLNs (A) and back skin (B).
Images show organs from individual mice. (C) Dextran-FITC (40 kD) was injected in the left footpad of Atg5WT and Atg5ΔProx1 mice 5 d after OVA + CFA
injection. 30 min later, dextran-FITC mean fluorescence intensity (MFI) was measured in draining (popliteal and inguinal) LNs to evaluate lymphatic vessel
draining functions. Right footpads were used as ipsilateral controls to remove background signal. Data are representative of two independent experiments,
four or five mice/group each. (C) Unpaired t test. Error bars correspond to lower and higher values for each group.
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Figure S5. Autophagy in LECs induces the degradation of SphK1. (A) PSSM scores for SphK1 and SphK2 amino acid sequences. (B) SphK1, SphK2, and
autophagosome (LC3-GFP+ organelles) staining in LECs sorted from LC3-GFP mice cultured and starved in HBSS + CQ for 4 h. Data are representative of three
independent experiments with two or three mice/group. (C) mRNA levels of SphK1, SphK2, and SPGL1 (Sphingosine lyase 1) in LECs sorted from dLNs of Tx-
treated Atg5WT and Atg5ΔProx1 CIA mice at day 31 (six or seven mice/group). (D) Western blot showing SphK1 protein levels and LC3-II/LC3-I ratios in human
iLECs, cultured and starved or not for 4 h. Data are representative of two independent experiments. LC3-I, 14 kD; LC3-II, 16 kD; β-actin, 43 kD; SphK1, ±70 kD.
(E) LECs sorted from LN cultures of LC3-GFP mice were stimulated in vitro with either CQ or IFN-γ, and autophagosomes (LC3-GFP+ organelles) were assessed
by microscopy. Arrows show the relocalization of LC3-GFP protein into autophagosome vesicles. Data are representative of two independent experiments.
(F) LECs sorted from LEC/FRC cultures of Atg5WT LEC mice were cultured in the bottom part of a transwell membrane and stimulated or not with IFN-γ (1 µg/
ml) for 24 h. Activated CD4+ T cells treated or not with FTY-720 were added in the upper part. After 4 h, CD4+ T cell transmigration was analyzed by flow
cytometry in the bottom part. Results are expressed as the ratio of migrated CD4+ T cells normalized to the control group (untreated WT LECs without FTY-
720). Data are representative of four independent mice. Unpaired t test (C and D) and one-way ANOVA (F). * P < 0.05 and *** P < 0.001. Error bars correspond
to lower and higher values for each group (C and D) and to SEM (F).
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